MORGAN STANLEY

Position in DNLI — Denali Therapeutics Inc.

CIK 895421 NEW YORK, NY

Back to DNLI Full portfolio

Position in DNLI

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$24,718,201

+$3,506,870 QoQ

Shares Held

961,050

-13.0% QoQ

Ownership

0.601%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 290 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 64% Shared 0% None 36%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. DNLI ranks #83 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

All Filings in DNLI

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,718,201	961,050	-13.0%	Shares	Defined	2026-08-13
2026-03-31	$21,211,331	1,104,757	-9.4%	Shares	Defined	2026-05-15
2025-12-31	$20,139,785	1,219,854	-27.8%	Shares	Defined	2026-05-27
2025-09-30	$24,531,419	1,689,492	+28.8%	Shares	Defined	2026-05-27
2025-06-30	$18,355,097	1,312,016	+4.7%	Shares	Defined	2025-08-15
2025-03-31	$17,042,727	1,253,603	+2.0%	Shares	Defined	2025-05-15
2024-12-31	$25,049,868	1,229,140	-29.6%	Shares	Defined	2025-05-15
2024-09-30	$50,824,709	1,744,755	+42.6%	Shares	Defined	2025-05-14
2024-06-30	$28,418,442	1,223,878	+31.9%	Shares	Defined	2025-05-14
2024-03-31	$19,045,140	928,126	-5.1%	Shares	Defined	2024-10-17
2023-12-31	$20,976,995	977,493	-0.4%	Shares	Defined	2024-08-16
2023-09-30	$20,249,763	981,569	-8.9%	Shares	Defined	2023-11-15
2023-06-30	$31,778,901	1,076,886	+89.2%	Shares	Defined	2023-08-14
2023-03-31	$13,112,568	569,122	+31.6%	Shares	Defined	2023-05-15
2022-12-31	$12,027,432	432,486	-36.5%	Shares	Defined	2023-02-14
2022-09-30	$20,910,075	681,332	+61.1%	Shares	Defined	2022-11-14
2022-06-30	$12,449,209	423,011	-40.1%	Shares	Defined	2022-10-27
2022-03-31	$22,700,918	705,655	+145.7%	Shares	Defined	2022-10-27
2021-12-31	$12,811,704	287,258	-25.2%	Shares	Defined	2022-02-14
2021-09-30	$19,372,443	383,993	-10.9%	Shares	Defined	2021-11-15
2021-06-30	$33,810,146	431,032	-6.7%	Shares	Defined	2021-08-23
2021-03-31	$26,389,332	462,160	+110.6%	Shares	Defined	2021-05-17
2020-12-31	$18,379,287	219,428	-28.0%	Shares	Defined	2021-02-16
2020-09-30	$10,923,133	304,860	-4.4%	Shares	Defined	2020-11-13
2020-06-30	$7,711,654	318,927	+105.2%	Shares	Defined	2020-08-14
2020-03-31	$2,721,438	155,422	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.